BioXcel Therapeutics, Inc. (BTAI) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading BTAI…

BioXcel Therapeutics, Inc. (BTAI) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

BioXcel Therapeutics, Inc.

BTAI · CIK 1720893

4 · Aug 14, 2026 · Director Atkins Susan E. was granted 17K Stock Option (Right to Buy)

4

Director Atkins Susan E. was granted 17K Stock Option (Right to Buy)

Filed: Aug 14, 2026
Period: Aug 12, 2026
Accession: 0001104659-26-097388
Filer: BioXcel Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

OWNERSHIP DOCUMENT

xslF345X06/tm2623296-2_4seq1.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4OWNERSHIP DOCUMENTtm2623296-2_4seq1.xml
Open SEC.gov